Ketamine and lidocaine infusions for hard-to-treat chronic migraine
Part of Brain & nervous system, Pain clinical trials.
This study tests whether giving two pain-relieving medicines, ketamine and lidocaine, through an IV can help adults with chronic migraine that hasn't improved with other treatments. The goal is to see if this treatment reduces migraine pain and improves daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with chronic migraine (headaches on 15 or more days a month) that hasn't responded to other treatments
- You are able to attend study visits and follow the plan
- You are willing to sign a consent form
- You are not pregnant and do not have serious heart, liver, or psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a lidocaine infusion into an artery in the head can reduce severe chronic daily headaches. It is for people who have tried multiple treatments without enough relief.
This study tests if injecting lidocaine (a numbing medicine) into an artery in the head can reduce chronic migraine pain. It may help people who have frequent migraines and are already getting a brain imaging test.
This trial tests whether an IV dose of ketamine can reduce chronic daily headaches and is safe for people with this condition. It may help by lowering headache frequency and severity, but it also has several medicine and health-related safety checks.
This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.
This trial tests if adding lidocaine and ketamine to your current pain medicines can better control severe cancer-related pain that opioids alone haven't helped.
This study compares two pain-relieving medicines given through an IV to see which works better for people with difficult-to-treat face or mouth pain. It may help you if other treatments have not worked.
Hear when a new Refractory Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.